Clinical Trials Logo
  1. Home
  2. Tear Film Thickness
  3. NCT00469521
  4. Details
NCT00469521 Clinical Trial

Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness

Tear Film Thickness Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00469521
Other study ID # 5304
Secondary ID
Status Completed
Phase Phase 4
First received May 2, 2007
Last updated September 5, 2007

Study information
Verified date September 2007
Source Innovative Medical
Contact n/a
Is FDA regulated No
Health authority United States:Institution Review Board
Study type Interventional

Clinical Trial Summary

To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Normal, healthy volunteers 18 years or older

2. Males or females

3. Any race or ethnic background

Exclusion Criteria:

1. Corneal refractive surgery within 6 months of this study.

2. Contact lens use on day of examination.

3. Corneal ectasia

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

Intervention

Drug:
• Refresh Tears, 9582X

Locations
Country Name City State
United States Magill Research Center Institute MUSC Charleston South Carolina

Sponsors (1)
Lead Sponsor Collaborator
Innovative Medical

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Recruiting NCT02713399 - High-resolution Imaging of Tear Film Thickness in Contact Lenses Wearers With Optical Coherence Tomography (OCT). A Pilot Study